Noema Pharma

Basel, Switzerland

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Dec 2024

Series B

Top Investors

Sofinnova PartnersJeito CapitalPolaris PartnersForbion Capital PartnersEQT Life Sciences

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Noema Pharma's investors?

Noema Pharma's investors include Sofinnova Partners, Jeito Capital, Polaris Partners, Forbion Capital Partners, EQT Life Sciences.

Where is Noema Pharma headquartered?

Noema Pharma is headquartered in Basel, Switzerland.

What does Noema Pharma do?

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

What stage is Noema Pharma at?

Noema Pharma is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 11, 2024.

MLA

"Noema Pharma — Funding & Investors." VCBacked, December 11, 2024, https://www.vcbacked.co/company/noema-pharma. Accessed July 1, 2026.

APA

VCBacked. (2024). Noema Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/noema-pharma

Wikipedia (cite web)

{{cite web |title=Noema Pharma — Funding & Investors |url=https://www.vcbacked.co/company/noema-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 11, 2024.